Eisai Korea Inc.
34
3
4
28
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
2.9%
1 terminated/withdrawn out of 34 trials
96.6%
+10.1% vs industry average
41%
14 trials in Phase 3/4
29%
8 of 28 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (34)
A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice
Role: lead
A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease
Role: lead
A Study of Filgotinib in Korean Participants With Rheumatoid Arthritis
Role: lead
A Post Marketing Surveillance Study of Equfina Tablet 50 Milligram (mg)
Role: lead
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
Role: lead
A Study to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Participants With Focal Onset Seizures With or Without Focal to Bilateral Tonic-clonic Seizures
Role: lead
A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
Role: lead
A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients
Role: lead
A Study of Lenvima (Lenvatinib) in Korean Unresectable Hepatocellular Carcinoma (uHCC) Participants
Role: lead
A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer
Role: lead
A Study for Tecfidera (Dimethyl Fumarate) Capsules in Korean Participants With Relapsing-Remitting Multiple Sclerosis
Role: lead
The Clinical Response of Choline Acetyltransferase and Apolipoprotein Epsilon Gene Polymorphisms to Donepezil in Alzheimer's Disease
Role: lead
Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy
Role: lead
Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation
Role: lead
Alzheimer's Disease Long-term Follow-up Study (ALF Study)
Role: lead
Post-Marketing Surveillance of Lenvima in Korean Patients
Role: lead
A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting
Role: lead
Nivolumab and Eribulin in HER2 Negative Metastatic Breast Cancer
Role: collaborator
A Study of Fycompa (Perampanel) in Korean Participants
Role: lead
Symbenda Post-Marketing Surveillance (PMS)
Role: lead